Pro Share Advisors LLC Amylyx Pharmaceuticals, Inc. Transaction History

Pro Share Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$1.62 - $2.71 $4,655 - $7,788	-2,874 Reduced 20.72%	11,000 $20,000
Q1 2024 May 08, 2024	BUY	$2.71 - $19.57 $3,124 - $22,564	1,153 Added 9.06%	13,874 $39,000
Q4 2023 Feb 14, 2024	BUY	$12.07 - $18.46 $20,700 - $31,658	1,715 Added 15.58%	12,721 $187,000
Q3 2023 Nov 13, 2023	BUY	$18.08 - $23.45 $976 - $1,266	54 Added 0.49%	11,006 $201,000
Q2 2023 Aug 10, 2023	BUY	$20.98 - $31.42 $8,895 - $13,322	424 Added 4.03%	10,952 $236,000
Q1 2023 May 11, 2023	SELL	$27.71 - $40.93 $39,902 - $58,939	-1,440 Reduced 12.03%	10,528 $308,000
Q4 2022 Feb 02, 2023	BUY	$29.75 - $39.26 $356,048 - $469,863	11,968 New	11,968 $442,000

127

44.4M

235K

530K

Ticker AMLX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,533,200
Market Cap $310M
Description
Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.